Annelated indolo (3,2-c)-lactams
CA 2005974 A1 · Owner: Hamminga, Derk · Inventors: Van Wijngaarden, Ineke; Wouters, Wouter; Haeck, Hans H.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Abstract, The invention relates to a group of new annelated indolo 3,2-c lactam derivatives of the formula having an antagonistic activity on 5-HT receptors. The compounds can be used for the treatment of symptoms which are caused by excessive stimulation of said receptors in the gastrointestinal system, the central nervous system the cardiovascular system, the respiratory system and for, alleviating or preventing withdrawal symptoms which are induced by abuse of drugs.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 19, 1989. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 19, 2009.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 19, 2011.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.